Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry

BACKGROUND: To this day, there is no data concerning guideline adherence on P2Y12-inhibitors in Austria. Prasugrel and ticagrelor have been shown to be superior to clopidogrel in the treatment of acute coronary syndromes (ACS). However, recent data from European registries showed a reluctant prescri...

Descripción completa

Detalles Bibliográficos
Autores principales: Tscharre, Maximilian, Egger, Florian, Machata, Matthias, Rohla, Miklos, Michael, Nadia, Neumayr, Manuel, Zweiker, Robert, Hajos, Johannes, Adlbrecht, Christopher, Suppan, Markus, Helmreich, Wolfgang, Eber, Bernd, Huber, Kurt, Weiss, Thomas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478120/
https://www.ncbi.nlm.nih.gov/pubmed/28632784
http://dx.doi.org/10.1371/journal.pone.0179349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478120/
https://www.ncbi.nlm.nih.gov/pubmed/28632784
http://dx.doi.org/10.1371/journal.pone.0179349

Ejemplares similares